1. Research and development aspects of oral controlled release systems;Qiu,2000
2. Qiu Y. Design and evaluation of oral modified-release dosage forms based on drug property and delivery technology. Proc. CAE/AAPS/CPA/CRS/FIP/APSTJ Conference: Oral Controlled Release Development and Technology. Shanghai; 2007. p. 34–43.
3. Oxybutynin extended release and tolterodine immediate release;Getsios;Clin Drug Invest,2004
4. Guidance for Industry: SUPAC-MR: Modified Release Solid Oral Dosage Forms Scale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls. In vitro dissolution testing and in vivo bioequivalence documentation. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research; 1997.
5. Handbook of pharmaceutical controlled release technology,2000